P6-25 oecutive hiwe year balance sheet and income statements of Anne Gibson Corpo ration follow ANNE GIBSON CORPORATION Balance Sheet December 31, 2007 throwh December 31, 2011 ( Dan in thomanda 2010 2005 Act Current Cash $47.000 46.000 45000 44,000 541,000 Marketable contes 1,000 Accue lew allow $1,000 December 31, 2011 $200, December 31, 2010 $900, December 31, 2009 $800, December 31, 2008 $1,200, December 31, 2007 131,000 126.000 12700 126,000 125.000 Inventor 122,000 124.000 125.000 127,000 125.000 Prepaid expenses 2.000 1,000 1.000 Total current VOS.200 DOO 302.000 301.000 200 Property, plant and 240,000 239.000 218.000 237.500 254.000 Other 10.000 8000 7.000 6.500 7.000 Tec 355590 355000 5 SO 37 Lists and ockholders' equity Curren Bas Accue $72,000 5 73,000 $75,000 $76,000 5.78.500 Accel 26,000 25.000 25.900 26,000 26,900 Income 11,500 12.000 13.000 12.000 11 000 Total current liabilities TOM.500 11600102300 11400113300 Long-term debe 68,000 0.000 58.000 60,000 62.000 Deferred income to 25,000 24.000 21/1000 22,000 21.000 Sedholders' equity 3$2,700 356,000 353.500 348.800 9300 Toallabies and stockholders equity 5555,200 $550.000 $548,000 $545.000 $538.000 ANNE GIBSON CORPORATION Statement of Earnings For Years Ended December 31, 2007-2011 In thund, opt perhard 2011 2010 2005 2007 Net $$80,000 $910,000 $540,000 $225.000 $820,000 Cost of goods sold 240.000 760.000 704.000 65.000 692.000 Group 150.000 136.000 15000 120.000 Selling and administrative pere 53,000 2.000 50,000 49.800 49,000 Interest Expene 00 5.00 5,800 6,000 Ermengoper before 80,100 92.100 0,200 73,000 Income 26,000 27.500 28,000 23.000 23.500 Ne mig 64,100 5331110 sosed En per share 12 Required 4. Using year-end balance sheet figures, compute the following for the maximum number of years, based on the available data 1. Days' sales in receivables 2. Accounts receivable tirnover 3. Accounts receivable turnover in days 4. Days' sales in inventory 5. Inventory turnover 6. Inventory turnover in days 7. Operating cycle 8. Working capital 9. Cumentatie 10. Acid-test ratio 11. Cash ratio 12. Sales to working capital